Aquablation of the Prostate: Single-center Results of a Non-selected, Consecutive Patient Cohort

Overview

Journal World J Urol

Specialty Urology

Date 2018 Oct 6

PMID 30288598

Citations 17

Authors

T Bach

I Giannakis

A Bachmann

C Fiori

Fernando Gomez-Sancha

T R W Herrmann

C Netsch

M Rieken

C M Scoffone

L Tunc

J J Rassweiler

E Liatsikos

Affiliations

Soon will be listed here.

Abstract

Purpose: Aquablation of the prostate using the AquaBeam™ system promises equivalent functional outcomes, reduced learning curve, and improved sexual function compared to transurethral prostate resection as shown in prospective randomized trials. This prospective cohort study aims to evaluate if published results can be transferred into the clinical routine in a non-selected patient collective.

Methods: This study includes all patients treated between September 2017 and June 2018 with Aquablation of the prostate. Patients have been evaluated prospectively for the perioperative course and early follow-up. Besides voiding parameter and symptom score, TRUS-volume change, ejaculatory function, and adverse events have been recorded.

Results: 118 consecutive patients have been treated in the given time. Aquablation could be carried out successfully in all patients. IPSS, QoL, Qmax, and PVR improved significantly after the procedure and continued to improve during 3-month follow-up. Mean OR time was 20 min, TRUS volume decreased by 65%, and 73% of the patients retained antegrade ejaculation. Thirteen adverse events (> Clavien-Dindo I) occurred in 10 patients.

Conclusion: The surgical ablation of the prostate using Aquablation achieved significant and immediate improvement of functional voiding parameters Qmax and PVR as well as symptomatic improvement of IPSS and QoL. Aquablation seems to be safe and effective with a low perioperative complication profile even in a non-selected group of patients.

Citing Articles

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta-analysis.

Bhatia A, Titus R, Porto J, Goradia R, Shah K, Lopategui D BJUI Compass. 2025; 5(12):1231-1245.

PMID: 39744077 PMC: 11685169. DOI: 10.1002/bco2.454.

Assessing Micturition, sexual function, and endoscopic outcomes one year after Aquablation: a single center prospective study.

Amparore D, De Cillis S, Quara A, Sica M, Ortenzi M, Piramide F World J Urol. 2024; 43(1):20.

PMID: 39653839 DOI: 10.1007/s00345-024-05380-9.

WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm and 80-150-cm prostates.

Berjaoui M, Nguyen D, Almousa S, Daher K, Barber N, Bidair M BJUI Compass. 2024; 5(11):1023-1033.

PMID: 39539565 PMC: 11557270. DOI: 10.1002/bco2.430.

Ejaculation physiology and dysfunction after BPH surgery: the role of the new MISTs.

Sibona M, Destefanis P, Vercelli E, Secco S, Gontero P, Cindolo L Prostate Cancer Prostatic Dis. 2023; 26(3):475-482.

PMID: 37500787 DOI: 10.1038/s41391-023-00686-y.

Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.

Nguyen D, Li T, Ferreira R, Berjaoui M, Nguyen A, Chughtai B Prostate Cancer Prostatic Dis. 2023; 27(1):22-28.

PMID: 37081044 DOI: 10.1038/s41391-023-00669-z.

References

Trueman P, Hood S, NAYAK U, Mrazek M . Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int. 1999; 83(4):410-5. DOI: 10.1046/j.1464-410x.1999.00966.x. View

Basting R, Djakovic N, Widmann P . Use of water jet resection in organ-sparing kidney surgery. J Endourol. 2000; 14(6):501-5. DOI: 10.1089/end.2000.14.501. View

Honl M, Rentzsch R, Lampe F, Muller V, Dierk O, Hille E . [Water jet cutting for bones and bone cement--parameter study of possibilities and limits of a new method]. Biomed Tech (Berl). 2000; 45(9):222-7. DOI: 10.1515/bmte.2000.45.9.222. View

Oertel J, Gaab M, Piek J . Waterjet resection of brain metastases - first clinical results with 10 patients. Eur J Surg Oncol. 2003; 29(4):407-14. DOI: 10.1053/ejso.2002.1428. View

Wilson L, Gilling P, Williams A, Kennett K, Frampton C, Westenberg A . A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol. 2006; 50(3):569-73. DOI: 10.1016/j.eururo.2006.04.002. View

Rau H, Duessel A, Wurzbacher S . The use of water-jet dissection in open and laparoscopic liver resection. HPB (Oxford). 2008; 10(4):275-80. PMC: 2518306. DOI: 10.1080/13651820802167706. View

Herrmann T, Georgiou A, Bach T, Gross A, Oelke M . Laser treatments of the prostate vs TURP/ open prostatectomy: systematic review of urodynamic data. Minerva Urol Nefrol. 2009; 61(3):309-24. View

Nagele U, Kugler M, Nicklas A, Merseburger A, Walcher U, Mikuz G . Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection. World J Urol. 2011; 29(4):423-7. DOI: 10.1007/s00345-011-0653-8. View

Fritsche H, Otto W, Eder F, Hofstadter F, Denzinger S, Chaussy C . Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study. J Endourol. 2011; 25(10):1599-603. DOI: 10.1089/end.2011.0042. View

10.

Cornu J, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C . A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. Eur Urol. 2014; 67(6):1066-1096. DOI: 10.1016/j.eururo.2014.06.017. View

11.

Faber K, de Abreu A, Ramos P, Aljuri N, Mantri S, Gill I . Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia. J Endourol. 2014; 29(1):63-9. DOI: 10.1089/end.2014.0304. View

12.

Gilling P, Reuther R, Kahokehr A, Fraundorfer M . Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int. 2015; 117(6):923-9. DOI: 10.1111/bju.13358. View

13.

Lin Y, Wu X, Xu A, Ren R, Zhou X, Wen Y . Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. World J Urol. 2015; 34(9):1207-19. DOI: 10.1007/s00345-015-1735-9. View

14.

Cornu J . Bipolar, Monopolar, Photovaporization of the Prostate, or Holmium Laser Enucleation of the Prostate: How to Choose What's Best?. Urol Clin North Am. 2016; 43(3):377-84. DOI: 10.1016/j.ucl.2016.04.006. View

15.

Herrmann T . Enucleation is enucleation is enucleation is enucleation. World J Urol. 2016; 34(10):1353-5. DOI: 10.1007/s00345-016-1922-3. View

16.

Herrmann T . [Long-term outcome after endoscopic enucleation of the prostate : From monopolar enucleation to HoLEP and from HoLEP to EEP]. Urologe A. 2016; 55(11):1446-1454. DOI: 10.1007/s00120-016-0245-8. View

17.

Gilling P, Anderson P, Tan A . Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results. J Urol. 2017; 197(6):1565-1572. DOI: 10.1016/j.juro.2017.01.056. View

18.

Lim K . Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017; 4(3):148-151. PMC: 5717991. DOI: 10.1016/j.ajur.2017.06.004. View

19.

Desai M, Singh A, Abhishek S, Laddha A, Pandya H, Ashrafi A . Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients. BJU Int. 2018; 121(6):945-951. DOI: 10.1111/bju.14126. View

20.

Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T . WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol. 2018; 199(5):1252-1261. DOI: 10.1016/j.juro.2017.12.065. View